Guizhou Bailing Group Pharmaceutical Co., Ltd.

Guizhou Bailing Group Pharmaceutical Co., Ltd.

002424.SZ - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$5.87B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Guizhou Bailing Group Pharmaceutical Co., Ltd.Guizhou Bailing Group Pharmaceutical Co., Ltd.-43.6--4%4.20.3
$6.84

Current Fair Value

61.3% upside

Undervalued by 61.3% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$5.87 Billion
Enterprise Value$6.62 Billion
Earnings per Share$-0.08
Beta0.26
Outstanding Shares1,365,009,688

Return

Return on Equity-4.05%ROE
Return on Assets-2.30%
Return on Invested Capital4.39%

Valuation & Multiples

P/E Ratio-43.58P/E Ratio
PEG70.69PEG
Price to Sales4.24Price to Sales
Price to Book Ratio2.12Price to Book Ratio
Enterprise Value to Revenue2.81
Enterprise Value to EBIT45.82
Enterprise Value to Net Income-52
Total Debt to Enterprise0.14
Debt to Equity0.29Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Guizhou Bailing Group Pharmaceutical Co., Ltd.

5,715 employees
CEO: Min Niu

Operating within China, Guizhou Bailing Group Pharmaceutical Co., Ltd. specializes in the full spectrum of activities for traditional Chinese medicine, from initial research and development to manufacturing and market distribution. The c...